Expression, purification, and biological characterization of recombinant human interleukin‐31 protein

Author:

Chen Jing12ORCID,Zheng Yuxin2,Wang Lixian2,Pang Xuefei2,Gao Feng2,Xiao Haixia23,Huo Nairui1

Affiliation:

1. College of Veterinary Medicine Shanxi Agricultural University Taigu China

2. Laboratory of Protein Engineering and Vaccines, Tianjin Institute of Industrial Biotechnology Chinese Academy of Sciences Tianjin China

3. National Technology Innovation Center of Synthetic Biology Tianjin China

Abstract

AbstractInterleukin‐31 (IL‐31), belonging to the IL‐6 cytokine family, is involved in skin inflammation and pruritus, as well as some tumors’ progression. Here, we reported the expression and purification of recombinant human IL‐31 (rhIL‐31) using a prokaryotic system. This recombinant protein was expressed in the form of inclusion bodies, refolded and purified by size‐exclusion chromatography. Circular dichroism analysis revealed that the secondary structure of rhIL‐31 was mainly composed of alpha‐helix, which is in consistence with the 3D model structure built by AlphaFold server. In vitro studies showed that rhIL‐31 exhibited a good binding ability to the recombinant hIL‐31 receptor alpha fused with human Fc fragment (rhIL‐31RA‐hFc) with EC50 value of 16.36 µg/mL in ELISA assay. Meanwhile, flow cytometry demonstrated that rhIL‐31 was able to bind to hIL‐31RA or hOSMRβ expressed on the cell surface, independently. Furthermore, rhIL‐31 could induce the phosphorylation of STAT3 in A549 cells. In conclusion, the prepared rhIL‐31 in this study possesses the binding ability to its receptors, and can activate the signal pathway of JAK/STAT. Thus, it can be applied in further studies, including investigation of hIL‐31‐related diseases, structural analysis, and development of therapeutic drugs, and monoclonal antibodies targeting hIL‐31.

Funder

National Key Research and Development Program of China

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3